Publisher
Springer Science and Business Media LLC
Reference58 articles.
1. Food and Drug Administration. Guidance for industry: extended release oral dosage forms-development, evaluation, and application of in vitro/in vivo correlations. 1997.
2. Godin B, Touitou E. Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models. Adv Drug Deliv Rev. 2007. https://doi.org/10.1016/j.addr.2007.07.004.
3. Valiveti S, Paudel KS, Hammell DC, Hamad MO, Chen J, Crooks PA, Stinchcomb AL. In vitro/in vivo correlation of transdermal naltrexone prodrugs in hairless guinea pigs. Pharm Res. 2005. https://doi.org/10.1007/s11095-005-4593-0.
4. Trends in the topical delivery of dermatology medications 2017 [Available from: https://www.manufacturingchemist.com/news/article_page/Trends_in_the_topical_delivery_of_dermatology_medications/129282.
5. Khire A, Vavia P. Bioavailability, bioequivalence, and in vitro-in vivo correlation of oxybutynin transdermal patch in rabbits. Drug Deliv Transl Res. 2014. https://doi.org/10.1007/s13346-013-0170-y.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献